Latest News

Paving the Way for AI’s Potential in Clinical Trials: Q&A With Rust Felix, CEO and Co-founder of Slope
Paving the Way for AI’s Potential in Clinical Trials: Q&A With Rust Felix, CEO and Co-founder of Slope

April 24th 2024

Felix addresses a variety of topics around artificial intelligence including challenges, streamlining data management, and human intervention.

Image credit: Crystal light | stock.adobe.com
FDA Grants Priority Review to sBLA for Jemperli plus Chemotherapy for Adults with Primary Advanced, Recurrent Endometrial Cancer

April 24th 2024

Image credit: Pixel-Shot | stock.adobe.com
The Consequences of Underrepresentation in Clinical Trial Design

April 23rd 2024

Image credit: MdBabul | stock.adobe.com
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia

April 23rd 2024

Creating Standardized eCOA Solutions
Creating Standardized eCOA Solutions

April 23rd 2024

Conference Coverage

View All
SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials
SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials

February 19th 2024

SCOPE 2024: Alex Deyle of Flatiron Health Discusses RWD in Clinical Trials
SCOPE 2024: Alex Deyle of Flatiron Health Discusses RWD in Clinical Trials

February 14th 2024

SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators
SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators

February 13th 2024

SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden
SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden

February 13th 2024

Latest Videos
Podcasts
© Alex from the Rock - © Alex from the Rock - stock.adobe.com
Rinol Alaj, Jaclyn Patterson, Applied Clincial Trials Podcast

All News

© 2024 MJH Life Sciences

All rights reserved.